26. Moechars D., Lorent K., DeStrooper B., Dewacher I. and Van Leuven F. (1996) Expression in brain of amyloid
precursor protein mutated in the Æ-secretase site causes disturbed behaviour, neuronal degeneration and premature
death in transgenic mice. Eur. molec. Biol. Org. J. 15, 1265–1274.
27. Morris R. G. M., Schenk F., Tweedie F. and Jarrard L. E. (1990) Ibotenate lesions of hippocampus and or subiculum
dissociating components of allocentric spatial learning. Eur. J. Neurosci. 2, 1016–1028.
28. Mucke L., Abraham C. R., Ruppe M. D., Rockenstein E. M., Toggas S. M., Alford M. and Masliah E. (1995)
Protection against HIV-1 gp120-induced brain damage by neuronal overexpression of amyloid protein precursor
(APP). J. exp. Med. 181, 1551–1556.
29. Mucke L., Masliah E., Johnson W. B., Ruppe M. D., Alford M., Rockenstein E. M., Mallory M. and Abraham
C. R. (1994) Synaptotrophic eVects of human amyloid â-protein precursor in the cortex of transgenic mice. Brain Res.
666, 151–167.
30. Owen E. H., Logue S. F., Rasmussen D. L. and Wehner J. M. (1997) Assessment of learning by the Morris water task
and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene
mutations and quantitative trait loci analyses. Neuroscience 80, 1087–1099.
31. Roch J.-M., Masliah E., Roch-Levecq A. C., Sundsmo M. P., Otero D. A. C., Veinbergs I. and Saitoh T. (1994)
Increase in synaptic density and memory retention by a peptide representing the trophic domain of the amyloid b/A4
protein precursor. Proc. natn. Acad. Sci. U.S.A. 91, 7450–7454.
32. Routtenberg A. (1997) Measuring memory in a mouse model of Alzheimer's disease. Science 277, 839–840.
33. Saitoh T. and Mook-Jung I. (1996) Commentary: Is understanding the biological function of APP important in
understanding Alzheimer's disease. Alzheimer's Dis. Rev. 1, 30–36.
34. Sandbrink R., Hartmann T., Masters C. L. and Beyreuther K. (1996) Genes contributing to Alzheimer's disease.
Molec. Psychiat. 1, 27–40.
35. ScheV S. W. and Price D. A. (1993) Synapse loss in the temporal lobe in Alzheimer's disease. Ann. Neurol. 33,
190–200.
36. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W.,
Ardson L., Levy-Lahad E., Viitanen M., Peskin E., Poorkaj P., Schellenberg G., Tanzi R. E., Wasco W., Lannfelt L.,
Selkoe D. and Younkin S. (1996) Secreted amyloid â-protein similar to that in the senile plaques of Alzheimer's disease
is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med.
2, 864–870.
37. Seabrook G. R., Easter A., Dawson G. R. and Bowery B. J. (1997) Modulation of long term potentiation in CA1
region of mouse hippocampal brain slices by GABA-A receptor benzodiazepine site ligands. Neuropharmacology 366,
823–830.
38. Selkoe D. J. (1994) Cell biology of the amyloid â-protein precursor and the mechanism of Alzheimer's disease. A. Rev.
Cell Biol. 10, 373–403.
39. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlosmacher M., Whaley J.,
Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Lieberberg I. and Schenk D. (1992) Isolation and
quantitation of soluble Alzheimer's â-peptide from biological fluids. Nature 359, 325–327.
40. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., ShaVer L., Cai X-D., McKay D. M., Tinter R., Frangione
B. and Younkin S. G. (1992) Production of the Alzheimer amyloid beta protein by normal proteolytic processing.
Science 258, 126–129.
41. Small D. H., Clarris H. L., Williamson T. G., Reed G., Key B., Mok S. S., Beyreuther K., Masters C. L. and
Nurcombe V. (1996) Neurite-outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease.
Alzheimer's Dis. Rev. 1, 21–29.
42. Small D. H., Nurcombe V., Reed G., Clarris H., Moir R., Beyreuther K. and Masters C. L. (1994) A heparin-binding
domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth.
J. Neurosci. 14, 2117–2127.
43. Smith-Swintosky V. L., Pettigrew L. C., Craddock S. D., Culwell A. R., Rydel R. E. and Mattson M. P. (1994)
Secreted forms of â-amyloid precursor protein protect against ischaemic brain injury. J. Neurochem. 63, 781–784.
44. Sola C., Garcia-Ladona F. J., Sarassa M., Mengod G., Probst A., Palacios G. and Palacios J. M. (1993) Beta APP
gene expression is increased in the rat brain after motor neuron axotomy. Eur. J. Neurosci. 5, 795–808.
45. Sommer B., Abramovski D., Burki K., Dixon K., Duke M., Kelly P., Lederman B., Paganetti P., Probst A.,
Sturcher-Pierrat C., Wiederhold K-H. and Staufenbiel M. (1996) Animal models for Alzheimer's disease based on
genetics and pathology. Soc. Neurosci. Abstr. 19.9, 25.
46. Svennerholm L. and Gottfries C-G. (1994) Membrane lipids, selectively diminished in Alzheimer brains suggest
synapse loss as a primary event in early-onset form (Type I) and demyelination in late-onset form (Type II).
J. Neurochem. 62, 1039–1047.
47. Tanzi R. E., Kovacs D. M., Kim T.-M., Moir R. D., Guenette S. Y. and Wasco W. (1996) The presenilin genes and
their role in early-onset familial Alzheimer's disease. Alzheimer's Dis. Rev. 1, 91–98.
48. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A. and Katzman R. (1991)
Physical basis of cognitive alterations in Alzheimer's disease: synaptic loss is the major correlate of cognitive
impairment. Ann. Neurol. 30, 572–580.
49. Wolozin B., Iwasaki K., Vito P., Ganjei J. K., Locana E., Sunderland T., Zhao B., Kusiak J. W., Wasco W. and
D'Adamio L. (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer
mutation. Science 274, 1710–1713.
50. Yamada T. and Kobayashi T. (1995) The mutations in amyloid precursor protein inhibit both Æ- and â-secretion.
Neurosci. Lett. 191, 103–106.
51. Zheng H., Jiang M., Trumbauer M., Sirinathsinghji D. J. S., Hopkins R., Smith D. W., Heavens R. P., Dawson
G. R., Boyce S., Conner M. W., Stevens K. A., Slunt H. H., Sisodia S. S., Chen H. Y. and Van der Ploeg L. H. T.
(1995) â-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81,
525–531.
